Publisher: Elsevier

Related content
Volume 1, Number 3, 1 June 2001

< previous issue | all issues | next issue >

Favourites:Add to Favourites

Pharmacology
pp. 203-212(10)
Authors: Khakh, B.; Dickenson, T.; Flavahan, N.; Chatterjee, P.; Thiemermann, C.; Newton, R.; Lindsay, M.; Harris, J.; Futscher, B.; Perretti, M.; Hoffman, P.; Brady, G.; Sharkey, K.; MacNaughton, W.; Furman, B.

Favourites:Add to Favourites

Respiratory and neuromuscular pharmacology
pp. 213-214(2)
Author: Kontinen, V.K.

Favourites:Add to Favourites
Favourites:Add to Favourites

New treatments for chronic obstructive pulmonary disease
pp. 217-222(6)
Author: Barnes, P.J.

Favourites:Add to Favourites

Selective muscarinic receptor antagonists for airway diseases
pp. 223-229(7)
Authors: Lee, A.M.; Jacoby, D.B.; Fryer, A.D.

Favourites:Add to Favourites

Anti-leukotrienes for asthma
pp. 230-234(5)
Author: Calhoun, W.J.

Favourites:Add to Favourites

Tachykinin receptor antagonists: potential in airways diseases
pp. 235-241(7)
Authors: Joos, G.F.; Pauwels, R.A.

Favourites:Add to Favourites

Interleukin-8 receptor antagonists in pulmonary diseases
pp. 242-247(6)
Authors: Hay, D.W.P.; Sarau, H.M.

Favourites:Add to Favourites

Eotaxin and asthma
pp. 248-253(6)
Authors: Pease, J.E.; Williams, T.J.

Favourites:Add to Favourites

The role of epidermal growth factor in mucus production
pp. 254-258(5)
Authors: Nadel, J.A.; Burgel, P.

Favourites:Add to Favourites

Airway smooth muscle as an immunomodulatory cell: a new target for pharmacotherapy?
pp. 259-264(6)
Authors: Lazaar, A.L.; Panettieri, R.A.

Favourites:Add to Favourites

Monoclonal antibodies as a strategy for pulmonary diseases
pp. 265-271(7)
Authors: Torphy, T.J.; Li, L.; Griswold, D.E.

Favourites:Add to Favourites

Prospects for gene therapy in lung disease
pp. 272-278(7)
Authors: Davies, J.C.; Geddes, D.M.; Alton, E.W.

Favourites:Add to Favourites

Musculoskeletal pharmacology
pp. 279-279(1)
Authors: Harris, J.B.; Cawston, T.E.

Favourites:Add to Favourites

Human muscle voltage-gated ion channels and hereditary disease
pp. 280-287(8)
Authors: Jurkat-Rott, K.; Lehmann-Horn, F.

Favourites:Add to Favourites

The mitochondrial genome and mitochondrial muscle disorders
pp. 288-293(6)
Authors: Schaefer, A.M.; Taylor, R.W.; Turnbull, D.M.

Favourites:Add to Favourites

Gene therapy: a strategy for the treatment of inherited muscle diseases?
pp. 294-299(6)
Authors: Moisset, P.; Tremblay, J.P.

Favourites:Add to Favourites
Favourites:Add to Favourites

Intracellular signaling pathways as a target for the treatment of rheumatoid arthritis
pp. 307-313(7)
Authors: Kumar, S.; Blake, S.M.; Emery, J.G.

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more